BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 670093)

  • 1. Drug sensitivity of an adriamycin-resistant mutant subline of mouse lymphoblastoma L5178Y cells.
    Nishimura T; Muto K; Tanaka N
    J Antibiot (Tokyo); 1978 May; 31(5):493-5. PubMed ID: 670093
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of adriamycin resistance in a subline of mouse lymphoblastoma L5178Y cells.
    Nishimura T; Suzuki H; Muto K; Tanaka N
    J Antibiot (Tokyo); 1979 May; 32(5):518-22. PubMed ID: 583339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation, drug sensitivity, and some biochemical and genetical properties of macromomycin-resistant mouse lymphoblastoma L5178Y cells.
    Suzuki H; Sugimoto Y; Tanaka K; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1984 May; 37(5):602-9. PubMed ID: 6547433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of action and resistance of antineoplastic agents].
    Tanaka N
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2245-51. PubMed ID: 6195971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
    Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
    J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced resistance in leukaemia L1210 to adriamycin and its cross-resistance to vincristine and bouvardin.
    Chitnis MP; Joshi SS; Gude RP; Menon RS
    Chemotherapy; 1982; 28(3):209-12. PubMed ID: 7094661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of adriamycin and radiation in combined treatment on mouse L-cells.
    Bistrović M; Nagy B; Maricić Z; Kolarić K
    Eur J Cancer (1965); 1978 Apr; 14(4):411-4. PubMed ID: 648561
    [No Abstract]   [Full Text] [Related]  

  • 8. Alteration of membrane-associated enzymes in drug-resistant sublines of mouse lymphoblastoma L5178Y cells.
    Sugimoto Y; Nishimura T; Suzuki H; Tanaka N
    J Antibiot (Tokyo); 1981 Sep; 34(9):1200-5. PubMed ID: 6173369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug sensitivity and some characteristics of a bleomycin-resistant subline of mouse lymphoblastoma L5178Y cells.
    Suzuki H; Nishimura T; Tanaka N
    J Antibiot (Tokyo); 1981 Sep; 34(9):1210-2. PubMed ID: 6173370
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines.
    Kunimoto S; Miura K; Umezawa K; Xu CZ; Masuda T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1984 Dec; 37(12):1697-702. PubMed ID: 6526737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies on resistance to anthracycline derivatives between doxorubicin-resistant mouse lymphoblastoma L5178Y cells and mouse leukemia P388 cells.
    Inouye Y; Oogose K; Nakamura S
    J Antibiot (Tokyo); 1990 Aug; 43(8):1021-7. PubMed ID: 2211351
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and preliminary characterization of an Adriamycin-resistant murine fibrosarcoma cell line.
    Giavazzi R; Scholar E; Hart IR
    Cancer Res; 1983 May; 43(5):2216-22. PubMed ID: 6831444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
    Chandrasekaran B; Dimling J; Capizzi RL
    Cancer Treat Rep; 1987 Feb; 71(2):195-6. PubMed ID: 2948640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
    Kiura K; Ohnoshi T; Ueoka H; Takigawa N; Tabata M; Segawa Y; Shibayama T; Kimura I
    Anticancer Drug Des; 1992 Dec; 7(6):463-70. PubMed ID: 1337430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased resistance of an interferon-resistant cell subline to the toxic effect of double-stranded RNA.
    Lackovic V; Borecký L
    Acta Virol; 1976 Aug; 20(4):347-8. PubMed ID: 9826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry studies of intracellular adriamycin in single cells in vitro.
    Durand RE; Olive PL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3489-94. PubMed ID: 7020929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro chemosensitivity and radiosensitivity of an adriamycin-resistant subline of human small cell lung cancer cells.
    Miyamoto H
    Acta Med Okayama; 1986 Apr; 40(2):75-81. PubMed ID: 3012966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
    Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
    Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.